Lv3
350 积分 2025-03-10 加入
再生障碍性贫血诊断与治疗中国指南（2022年版）
1天前
已完结
Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function
1个月前
已完结
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease
1个月前
已完结
IBD Matchmaking: Rational Combination Therapy
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
2个月前
已完结
Laboratory Markers of Platelet Production and Turnover
2个月前
已完结
Diet outperforms microbial transplant to drive microbiome recovery in mice
2个月前
已完结
APOB-48 shows potential as a biomarker to evaluate treatment response with apraglutide in short bowel syndrome, intestinal failure and colon-in-continuity
3个月前
已关闭
Can amylin-based drugs upstage GLP-1 agonists?
3个月前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
3个月前
已完结
皖公网安备34019202002308
